Low-Dose Adjuvant Aspirin Decreases Incidence of Recurrence Among Patients with Resected PI3K-Altered CRC By Ogkologos - September 30, 2025 62 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ALASCCA study Source RELATED ARTICLESMORE FROM AUTHOR Rucaparib Monotherapy Provides Significant and Durable Long-Term Benefit as First-Line Maintenance for Patients with Advanced Ovarian Cancer with and without HRD FDA Approves Belantamab Mafodotin-blmf for Relapsed or Refractory Multiple Myeloma Long-Term Follow-Up Data Support Longer RFS with Adjuvant Nivolumab Than with Ipilimumab in Patients with Melanoma at High Risk for Recurrence MOST POPULAR Utility of a Methylation-Based Multicancer Early Detection Test in Identifying Whom... July 4, 2023 I Received the COVID-19 Vaccine – Now What? February 8, 2021 Immunotherapy and… Nothing Else? Studies Test Potential Paradigm Shift in Cancer... February 23, 2023 ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) July 28, 2020 Load more HOT NEWS New on NCI’s Websites for December 2022 A Robust, Durable Activity of Atezolizumab Observed in a Diverse Cohort... Five Questions With…Desiree. Pioneer in Autism Diagnosis And Treatment Dies At 97
